Dimerix Limited Logo

Dimerix Limited

DXB.AX

(0.8)
Stock Price

0,36 AUD

-77.73% ROA

-282.99% ROE

-5.14x PER

Market Cap.

93.148.750,00 AUD

99.91% DER

0% Yield

-119.2% NPM

Dimerix Limited Stock Analysis

Dimerix Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dimerix Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (1%), which means it has a small amount of debt compared to the ownership it holds

2 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

3 ROE

Negative ROE (-173.72%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-83.67%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 PBV

The stock's elevated P/BV ratio (3.17x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Dimerix Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dimerix Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Dimerix Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dimerix Limited Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 5.343.004 100%
2002 4.154.000 -28.62%
2003 2.485.000 -67.16%
2004 2.732.000 9.04%
2005 1.369.138 -99.54%
2006 564 -242654.96%
2007 655.993 99.91%
2008 756.957 13.34%
2009 0 0%
2010 0 0%
2011 73.068 100%
2012 0 0%
2013 88.973 100%
2014 350.218 74.59%
2015 238.053 -47.12%
2016 610.272 60.99%
2017 554.617 -10.03%
2018 845.288 34.39%
2019 1.447.390 41.6%
2020 0 0%
2020 2.340.954 100%
2021 4.439.715 47.27%
2022 6.463.455 31.31%
2023 8.983.737 28.05%
2024 407.466 -2104.78%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dimerix Limited Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 212.440 100%
2014 131.963 -60.98%
2015 211.698 37.66%
2016 589.075 64.06%
2017 878.118 32.92%
2018 2.051.282 57.19%
2019 2.837.027 27.7%
2020 5.537.528 48.77%
2020 5.537.528 0%
2021 9.332.356 40.66%
2022 14.389.424 35.14%
2023 20.473.575 29.72%
2024 21.097.749 2.96%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dimerix Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 1.183.886 100%
2002 826.000 -43.33%
2003 818.014 -0.98%
2004 568.137 -43.98%
2005 713.829 20.41%
2006 1.169.919 38.98%
2007 1.210.996 3.39%
2008 1.982.283 38.91%
2009 157.731 -1156.75%
2010 78.005 -102.21%
2011 47.130 -65.51%
2012 13.072 -260.54%
2013 40.880 68.02%
2014 205.324 80.09%
2015 220.851 7.03%
2016 1.174.976 81.2%
2017 1.325.548 11.36%
2018 1.963.210 32.48%
2019 1.459.455 -34.52%
2020 1.299.820 -12.28%
2020 1.212.294 -7.22%
2021 1.555.757 22.08%
2022 2.436.236 36.14%
2023 2.280.679 -6.82%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dimerix Limited EBITDA
Year EBITDA Growth
1989 161.000
1990 -118.000 236.44%
1991 -554.000 78.7%
1992 2.000 27800%
1993 -40.000 105%
1994 -110.000 63.64%
1995 -100.000 -10%
1996 -87.651 -14.09%
1997 -105.714 17.09%
1998 703.971 115.02%
1999 1.120.891 37.2%
2000 -509.000 320.21%
2001 -4.070.000 87.49%
2002 -607.000 -570.51%
2003 -778.000 21.98%
2004 -464.000 -67.67%
2005 -484.410 4.21%
2006 -3.016.567 83.94%
2007 -1.884.230 -60.1%
2008 -1.193.563 -57.87%
2009 -512.429 -132.92%
2010 -402.820 -27.21%
2011 -401.816 -0.25%
2012 -417.443 3.74%
2013 -461.013 9.45%
2014 -590.198 21.89%
2015 -579.301 -1.88%
2016 -1.887.950 69.32%
2017 -2.311.630 18.33%
2018 -4.158.590 44.41%
2019 -4.328.930 3.93%
2020 -4.480.624 3.39%
2020 -6.904.860 35.11%
2021 -10.883.570 36.56%
2022 -16.904.700 35.62%
2023 -22.767.330 25.75%
2024 -25.187.050 9.61%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dimerix Limited Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 2.022.397 100%
2002 1.783.000 -13.43%
2003 1.127.300 -58.17%
2004 1.203.677 6.35%
2005 286.291 -320.44%
2006 564 -50660.82%
2007 546.220 99.9%
2008 442.142 -23.54%
2009 0 0%
2010 0 0%
2011 73.068 100%
2012 0 0%
2013 -88.316 100%
2014 263.408 133.53%
2015 238.053 -10.65%
2016 608.363 60.87%
2017 553.097 -9.99%
2018 838.866 34.07%
2019 1.442.713 41.85%
2020 0 0%
2020 2.327.425 100%
2021 4.395.114 47.05%
2022 6.412.910 31.46%
2023 8.927.728 28.17%
2024 407.466 -2091.04%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dimerix Limited Net Profit
Year Net Profit Growth
1989 90.000
1990 -119.000 175.63%
1991 -344.000 65.41%
1992 -1.000 -34300%
1993 -65.000 98.46%
1994 -137.000 52.55%
1995 -123.000 -11.38%
1996 -123.497 0.4%
1997 -140.000 11.79%
1998 598.173 123.4%
1999 646.298 7.45%
2000 -516.000 225.25%
2001 -4.200.000 87.71%
2002 -716.000 -486.59%
2003 -946.000 24.31%
2004 -676.000 -39.94%
2005 -595.797 -13.46%
2006 -11.161.018 94.66%
2007 -2.421.661 -360.88%
2008 -3.557.390 31.93%
2009 -4.128.738 13.84%
2010 -347.767 -1087.21%
2011 5.656 6248.64%
2012 -386.070 101.47%
2013 -517.098 25.34%
2014 -527.978 2.06%
2015 -679.539 22.3%
2016 -5.254.475 87.07%
2017 -1.758.532 -198.8%
2018 -3.319.726 47.03%
2019 -2.886.221 -15.02%
2020 -4.494.153 35.78%
2020 -4.494.153 0%
2021 -6.371.734 29.47%
2022 -10.490.579 39.26%
2023 -13.802.819 24%
2024 -17.075.083 19.16%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dimerix Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 1
1990 -1 200%
1991 -4 75%
1992 0 0%
1993 -4 100%
1994 -8 57.14%
1995 -6 -16.67%
1996 -3 -100%
1997 -3 0%
1998 11 127.27%
1999 11 -10%
2000 -8 225%
2001 -69 88.24%
2002 -9 -655.56%
2003 -8 -12.5%
2004 -4 -100%
2005 -1 -300%
2006 -10 90%
2007 -2 -900%
2008 -1 0%
2009 -1 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dimerix Limited Free Cashflow
Year Free Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 -200.000 100%
1992 -146.000 -36.99%
1993 -1.000 -14500%
1994 0 0%
1995 0 0%
1996 -3.000 100%
1997 -320.000 99.06%
1998 -1.069.000 70.07%
1999 -40.000 -2572.5%
2000 -96.000 58.33%
2001 -68.000 -41.18%
2002 -20.000 -240%
2003 -61.000 67.21%
2004 -32.680 -86.66%
2005 -2.037.833 98.4%
2006 -1.656.742 -23%
2007 -60.758 -2626.79%
2008 -119.175 49.02%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -5.882 100%
2015 -1.984 -196.47%
2016 -2.581 23.13%
2017 -3.228.975 99.92%
2018 -2.757.708 -17.09%
2019 -4.721.480 41.59%
2020 -6.370.010 25.88%
2021 -13.446.551 52.63%
2022 -4.410.225 -204.89%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dimerix Limited Operating Cashflow
Year Operating Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 -2.013.892 100%
2006 -1.656.742 -21.56%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 -3.225.432 100%
2018 -2.750.802 -17.25%
2019 -4.721.480 41.74%
2020 -6.360.438 25.77%
2021 -13.435.937 52.66%
2022 -4.410.225 -204.65%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dimerix Limited Capital Expenditure
Year Capital Expenditure Growth
1988 0
1989 0 0%
1990 0 0%
1991 200.000 100%
1992 146.000 -36.99%
1993 1.000 -14500%
1994 0 0%
1995 0 0%
1996 3.000 100%
1997 320.000 99.06%
1998 1.069.000 70.07%
1999 40.000 -2572.5%
2000 96.000 58.33%
2001 68.000 -41.18%
2002 20.000 -240%
2003 61.000 67.21%
2004 32.680 -86.66%
2005 23.941 -36.5%
2006 0 0%
2007 60.758 100%
2008 119.175 49.02%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 5.882 100%
2015 1.984 -196.47%
2016 2.581 23.13%
2017 3.543 27.15%
2018 6.906 48.7%
2019 0 0%
2020 9.572 100%
2021 10.614 9.82%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dimerix Limited Equity
Year Equity Growth
1988 1.525.000
1989 1.409.000 -8.23%
1990 1.046.000 -34.7%
1991 1.044.000 -0.19%
1992 1.410.000 25.96%
1993 1.741.000 19.01%
1994 1.724.000 -0.99%
1995 1.849.772 6.8%
1996 1.957.517 5.5%
1997 5.025.864 61.05%
1998 5.771.871 12.92%
1999 5.240.203 -10.15%
2000 640.427 -718.24%
2001 282.886 -126.39%
2002 -565.025 150.07%
2003 -170.377 -231.63%
2004 10.280.504 101.66%
2005 2.694.481 -281.54%
2006 1.414.772 -90.45%
2007 1.008.159 -40.33%
2008 341.976 -194.8%
2009 1.560.180 78.08%
2010 1.565.836 0.36%
2011 1.179.766 -32.72%
2012 1.707.138 30.89%
2013 1.179.160 -44.78%
2014 2.777.090 57.54%
2015 2.242.575 -23.83%
2016 2.629.675 14.72%
2017 6.857.955 61.66%
2018 4.202.877 -63.17%
2019 7.759.264 45.83%
2020 1.468.499 -428.38%
2021 14.422.640 89.82%
2022 5.963.119 -141.86%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dimerix Limited Assets
Year Assets Growth
1988 1.781.000
1989 1.727.000 -3.13%
1990 1.149.000 -50.3%
1991 1.161.000 1.03%
1992 1.636.000 29.03%
1993 2.033.000 19.53%
1994 1.981.000 -2.62%
1995 2.243.534 11.7%
1996 2.260.732 0.76%
1997 9.689.631 76.67%
1998 9.121.446 -6.23%
1999 7.901.573 -15.44%
2000 2.278.158 -246.84%
2001 1.890.609 -20.5%
2002 1.216.200 -55.45%
2003 1.827.671 33.46%
2004 10.521.001 82.63%
2005 3.038.236 -246.29%
2006 4.071.529 25.38%
2007 2.448.607 -66.28%
2008 385.333 -535.45%
2009 1.606.528 76.01%
2010 1.593.823 -0.8%
2011 1.214.290 -31.26%
2012 1.753.446 30.75%
2013 1.213.655 -44.48%
2014 2.968.733 59.12%
2015 2.525.300 -17.56%
2016 2.871.793 12.07%
2017 7.264.699 60.47%
2018 4.940.645 -47.04%
2019 10.389.011 52.44%
2020 9.420.704 -10.28%
2021 16.497.026 42.89%
2022 17.757.513 7.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dimerix Limited Liabilities
Year Liabilities Growth
1988 256.000
1989 318.000 19.5%
1990 103.000 -208.74%
1991 117.000 11.97%
1992 226.000 48.23%
1993 292.000 22.6%
1994 257.000 -13.62%
1995 393.762 34.73%
1996 303.215 -29.86%
1997 4.663.767 93.5%
1998 3.349.575 -39.23%
1999 2.661.369 -25.86%
2000 1.637.731 -62.5%
2001 1.607.723 -1.87%
2002 1.781.225 9.74%
2003 1.998.048 10.85%
2004 240.497 -730.8%
2005 343.755 30.04%
2006 2.656.757 87.06%
2007 1.440.448 -84.44%
2008 43.357 -3222.3%
2009 46.348 6.45%
2010 27.987 -65.61%
2011 34.524 18.93%
2012 46.308 25.45%
2013 34.495 -34.25%
2014 191.643 82%
2015 282.725 32.22%
2016 242.118 -16.77%
2017 406.744 40.47%
2018 737.768 44.87%
2019 2.629.747 71.95%
2020 7.952.205 66.93%
2021 2.074.386 -283.35%
2022 11.794.394 82.41%

Dimerix Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.03
Net Income per Share
-0.04
Price to Earning Ratio
-5.14x
Price To Sales Ratio
10.37x
POCF Ratio
-5.58
PFCF Ratio
-7.32
Price to Book Ratio
11.91
EV to Sales
10.14
EV Over EBITDA
-6.59
EV to Operating CashFlow
-7.16
EV to FreeCashFlow
-7.16
Earnings Yield
-0.19
FreeCashFlow Yield
-0.14
Market Cap
0,09 Bil.
Enterprise Value
0,09 Bil.
Graham Number
0.13
Graham NetNet
0.01

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.92
ROE
-3.6
Return On Assets
-0.72
Return On Capital Employed
-1.66
Net Income per EBT
1
EBT Per Ebit
0.55
Ebit per Revenue
-2.18
Effective Tax Rate
-0.82

Margins

Sales, General, & Administrative to Revenue
0.25
Research & Developement to Revenue
2.28
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
1
Operating Profit Margin
-2.18
Pretax Profit Margin
-1.19
Net Profit Margin
-1.19

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.04
Free CashFlow per Share
-0.04
Capex to Operating CashFlow
0
Capex to Revenue
-0
Capex to Depreciation
-0.04
Return on Invested Capital
-1.16
Return on Tangible Assets
-0.78
Days Sales Outstanding
388.15
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0.94
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0.02
Debt to Equity
1
Debt to Assets
0.34
Net Debt to EBITDA
0.15
Current Ratio
1.51
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
1
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
92154
Debt to Market Cap
0.06

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dimerix Limited Dividends
Year Dividends Growth
1998 0
1999 0 0%

Dimerix Limited Profile

About Dimerix Limited

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

CEO
Dr. Nina Webster B.Sc., M.B.A
Employee
0
Address
425 Smith Street
Fitzroy, 3065

Dimerix Limited Executives & BODs

Dimerix Limited Executives & BODs
# Name Age
1 Mr. Robert Shepherd
Chief Commercialisation Officer
70
2 Mr. Hamish George B.Com., C.A.
Chief Financial Officer & Company Secretary
70
3 Dr. David Everett Fuller BPharm, M.D., MBBS
Chief Medical Officer
70
4 Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D.
Chief Executive Officer, MD & Director
70
5 Mr. Kevin Donald George Pfleger BA (Hons), MA, Ph.D.
Chief Scientific Advisor
70

Dimerix Limited Competitors